Final rule 2026-12904
Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs Syndrome
The Food and Drug Administration (FDA) is classifying the external lower extremity nerve stimulator for Restless Legs Syndrome into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the external lower extremity nerve stimulator for Restless Legs Syndrome. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2026-12904
- Published
- Jun 26, 2026
- Effective
- Jun 26, 2026
- Comments close
- Not supplied
- Federal Register citation
- 91 FR 38508
Docket identifiers
- Docket No. FDA-2026-N-6713
CFR references
- Title 21, part 882